Percutaneous Treatment of Non-parasitic Splenic Cysts: Long-Term Results for Single- Versus Multiple-Session Treatment.

Autor: Akhan O; Department of Radiology, Hacettepe University School of Medicine, 6100, Sihhiye, Ankara, Turkey. oakhan@hacettepe.edu.tr., Dagoglu-Kartal MG; Department of Radiology, Istanbul University Istanbul Medical School, 34093, Çapa, Fatih, Istanbul, Turkey., Ciftci T; Department of Radiology, Hacettepe University School of Medicine, 6100, Sihhiye, Ankara, Turkey., Ozer C; Numune Training and Research Hospital Radiology Clinic, Ülkü Mahallesi Talatpaşa Bulvari No: 5, Altindag, 6080, Ankara, Turkey., Erbahceci A; Sadi Konuk Training and Research Hospital Radiology Clinic, Tevfik Saglam Caddesi No: 11, Zuhuratbaba, 34147, Istanbul, Turkey., Akinci D; Department of Radiology, Hacettepe University School of Medicine, 6100, Sihhiye, Ankara, Turkey.
Jazyk: angličtina
Zdroj: Cardiovascular and interventional radiology [Cardiovasc Intervent Radiol] 2017 Sep; Vol. 40 (9), pp. 1421-1430. Date of Electronic Publication: 2017 May 01.
DOI: 10.1007/s00270-017-1650-0
Abstrakt: Purpose: The aim of this study was to investigate the efficacy and safety of percutaneous sclerotherapy for non-parasitic splenic cysts (NPSCs). The secondary aims were to introduce puncture-aspiration-injection-reaspiration (PAIR) technique in the treatment of NPSCs and to compare multiple- and single-session techniques.
Materials and Methods: This retrospective study included 24 (17 females, 7 males) patients, treated between the years 1997 and 2015. Three techniques were used. Group A (n = 8), Group B (n = 6) and Group C (n = 10) were treated by PAIR, single-session catheterization and multiple-session catheterization, respectively. Since both PAIR and single-session catheterization techniques are carried out in a single session, Group A and Group B were evaluated in one group (Group A + B). Group A + B was compared with Group C in terms of patient demographics, the initial volume of the cysts, follow-up periods, complication and hospitalization rates and follow-up results. Recurrence and reduction rates were evaluated for two groups.
Results: Technical success rate was 100%. The mean follow-up period was 68.9 months. Recurrence detected in 7 (29.1%) patients. Final reduction rate was between 40.7 and 100% (median 96.4%) with a significant difference in cyst volume (p < 0.05). There was no significant difference regarding recurrence rates (p = 1) and the final reduction rates (p = 0.51) between the two groups.
Conclusion: Percutaneous sclerotherapy is a minimally invasive technique, preserving maximum tissue while effectively treating NPSCs. Single-session sclerotherapy which reduces hospitalization days and increases patient comfort is as effective as multi-session sclerotherapy as the initial procedure. This study supports that single-session sclerotherapy should be a valid treatment option.
Databáze: MEDLINE
Externí odkaz: